Helus Pharma is a company headquartered in Canada.
Helus Pharma develops novel serotonergic agonist therapies aimed at improving mental health conditions through neuroplasticity, with a focus on clinical stage treatments for anxiety and other neuropsychiatric disorders.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.